Citation Impact
Citing Papers
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data‐Driven Methodology Involving Three International Patient Cohorts
2016 Standout
Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment – a prospective, controlled study
2006
Objective and subjective assessment of sleep in chronic low back pain patients compared with healthy age and gender matched controls: a pilot study
2009
Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives
2010
The role and validity of actigraphy in sleep medicine: An update
2011 Standout
Modulating the immune response by oral zinc supplementation: a single approach for multiple diseases
2008
Sjögren's syndrome
2005 Standout
Association of Malignancy With Diseases Causing Interstitial Pulmonary Changes
2002
Rheumatoid arthritis
2016 Standout
Wearable biosensors for healthcare monitoring
2019 Standout
ACETAMINOPHEN-INDUCED HEPATOTOXICITY
2003 Standout
Mechanisms of idiosyncratic drug reactions: the case of felbamate
2002
Covalent Binding of Xenobiotics to Specific Proteins in the Liver
1997
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis
2009 Standout
Pheochromocytoma as an Endocrine Emergency
2003
Advances in metal-induced oxidative stress and human disease
2011 Standout
The interplay between innate and adaptive immunity regulates cancer development
2005
Selective Protein Covalent Binding and Target Organ Toxicity
1997
Hydroxychloroquine: From Malaria to Autoimmunity
2011 Standout
Pharmacological treatment of established rheumatoid arthritis
2003
Characteristics of Sleep in Older Persons With Chronic Pain
2010
Phaeochromocytoma
2005 Standout
PLGA-based nanoparticles: An overview of biomedical applications
2012 Standout
2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome
2016 Standout
Inflammation in Wound Repair: Molecular and Cellular Mechanisms
2007 Standout
Drug-Induced Hepatotoxicity
2003 Standout
The American college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials
1993 Standout
Acute anterior uveitis and HLA-B27
1991
Factors associated with abnormal Pap results in systemic lupus erythematosus
2004
Cancer and interstitial lung disease
2004
Cholesterol-lowering effect of hydroxychloroquine in patients with rheumatic disease: Reversal of deleterious effects of steroids on lipids
1990
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Diclofenac residues as the cause of vulture population decline in Pakistan
2004 StandoutNature
Dental caries
2017 Standout
Intraepidermal lymphocytes in psoriatic lesions are activated GMP‐17(TIA‐1)+CD8+CD3+ CTLs as determined by phenotypic analysis
1998 StandoutNobel
Cardiovascular manifestations of phaeochromocytoma
2011
Actigraphic monitoring (actigraphy) of circadian locomotor activity in schizophrenic patients with acute neuroleptic-induced akathisia
2000
Calcitonin in the Treatment of Transient Osteoporosis of the Hip
2003
Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors
2011 Standout
TFOS DEWS II Management and Therapy Report
2017 Standout
The Role of Actigraphy in the Study of Sleep and Circadian Rhythms
2003 Standout
The impact of endpoint measures in rheumatoid arthritis clinical trials
1992
Rheumatoid arthritis
2010 Standout
Ecotoxicology of human pharmaceuticals
2005 Standout
Time course of serum amyloid A response in myocardial infarction
1989
Methods for Collecting Saliva
1993 Standout
Diclofenac Sodium
1988
Idiopathic pulmonary fibrosis
2011 Standout
Diclofenac‐induced hepatitis: case report and literature review
1994
Untangling the Concepts of Disability, Frailty, and Comorbidity: Implications for Improved Targeting and Care
2004 Standout
The long‐term effects of non‐steroidal anti‐inflammatory drugs in osteoarthritis of the knee: a randomized placebo‐controlled trial
2000
The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina
1994 Standout
Brainstem modulation of pain during sleep and waking
2003
Musculoskeletal Aspects of Pregnancy
2005 Standout
A review of saliva: Normal composition, flow, and function
2001 Standout
Treatment of Sjögren's Syndrome–Associated Dry Eye
2011
Investigation of the relationship between the onset of arthritis and uveitis in genetically predisposed SKG mice
2015 StandoutNobel
Clinical Course and Prediction of Survival in Idiopathic Pulmonary Fibrosis
2010 Standout
ANTIMALARIAL AGENTS AND LUPUS
1994
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
2018 Standout
Sjögren's Syndrome
1981
The Diagnostic Applications of Saliva — A Review
2002
Corneal collagen crosslinking: a systematic review.
2014 Standout
How Much Saliva is Enough?
1991
Topical Fluorides in Caries Prevention and Management: A North American Perspective
2001
Primary Biliary Cirrhosis
2011 Standout
Xerostomia: Diagnosis and treatment
1983
Primary Sj�gren's syndrome treated with Efamol/Efavit
1984
Diclofenac-associated hepatotoxicity: Analysis of 180 cases reported to the food and drug administration as adverse reactions
1995
U.S. Medical Eligibility Criteria for Contraceptive Use, 2016
2016 Standout
Gold Nanoparticles: A Revival in Precious Metal Administration to Patients
2011 Standout
Pilocarpine for the treatment of xerostomia associated with salivary gland dysfunction
1986
Xerostomia. A neglected symptom
1987
Hypersensitivity to gold in gold sodium thiomalate-induced dermatosis
1999
Peripheral corneal disorders
1986
Some recent advances in HLA and skin diseases
1981
Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline
2014 Standout
Daily diary and ambulatory activity monitoring of sleep in patients with insomnia associated with chronic musculoskeletal pain
1998
Labial salivary gland biopsy in sjögren's syndrome
1984
Works of Y Scharf being referenced
Sialochemistry in evaluating bromhexine treatment of Sjögren's syndrome.
1979
Sialochemistry for diagnosis of Sjögren's syndrome in xerostomic patients
1981
Sialochemistry of patients with rheumatoid arthritis
1978
A COMPARATIVE STUDY OF NAPROXEN WITH DICLOFENAC SODIUM IN OSTEOATHROSIS OF THE KNEES
1982
Actigraphic measurements of sleep in rheumatoid arthritis: comparison of patients with low back pain and healthy controls.
1992
[Sulfasalazine in rheumatoid arthritis].
1991
A COMPARATIVE STUDY OF DICLOFENAC AND SULINDAC IN ANKYLOSING SPONDYLITIS
1980
THE INFLUENCE OF HL-A B27 ON THE CLINICAL PICTURE OF ANKYLOSING SPONDYLITIS
1979
Diclofenac-induced hepatotoxicity
1986
Cholestatic jaundice induced by gold salts treatment clinical and immunological aspects--report of one case and review of the literature.
1984
Effect of prolonged bromhexine therapy on Sjögren's syndrome.
1981
HL-A Antigens in Behçet’s Disease
1978
Intermittent claudiation with pheochromocytoma
1971
Chemical analysis of whole saliva in Sjögren's syndrome.
1987
Transient osteoporosis of the hip: case report and review of the literature.
1989
HYPOCHOLESTEROLAEMIA AND ABNORMAL HIGH-DENSITY LIPOPROTEIN IN RHEUMATOID ARTHRITIS
1985
Zinc metabolism in rheumatoid arthritis: plasma and urinary zinc and relationship to disease activity.
1997
Histocompatibility antigens (HLA) and uveitis
1980
Intermittent Claudication With Pheochromocytoma
1971
Systemic Lupus Erythematosus: Predisposition for Uterine Cervical Dysplasia
1994